We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSI icon
1301
Motorola Solutions
MSI
$70.3B
$70K ﹤0.01%
819
+709
+645% +$58K
PKX icon
1302
POSCO
PKX
$16.1B
$70K ﹤0.01%
1,105
+52
+5% +$3.11K
CSRA
1303
DELISTED
CSRA Inc.
CSRA
$70K ﹤0.01%
2,424
+124
+5% +$3.8K
CLB icon
1304
Core Laboratories
CLB
$518M
$69K ﹤0.01%
600
IYJ icon
1305
iShares US Industrials ETF
IYJ
$2B
$69K ﹤0.01%
1,100
NGVT icon
1306
Ingevity
NGVT
$2.59B
$69K ﹤0.01%
1,145
+27
+2% +$1.53K
C.PRC.CL
1307
DELISTED
Citigroup Inc.
C.PRC.CL
$69K ﹤0.01%
2,700
CMD
1308
DELISTED
Cantel Medical Corporation
CMD
$68K ﹤0.01%
850
AMLP icon
1309
Alerian MLP ETF
AMLP
$12.7B
$67K ﹤0.01%
1,066
LDOS icon
1310
Leidos
LDOS
$14.5B
$67K ﹤0.01%
1,319
+1,256
+1,994% +$64.7K
PBA icon
1311
Pembina Pipeline
PBA
$29B
$67K ﹤0.01%
2,125
RACE icon
1312
Ferrari
RACE
$66.8B
$67K ﹤0.01%
918
+351
+62% +$22.8K
FCPT icon
1313
Four Corners Property Trust
FCPT
$2.83B
$66K ﹤0.01%
2,939
NNBR icon
1314
NN Inc
NNBR
$273M
$66K ﹤0.01%
2,645
+145
+6% +$3.03K
PBE icon
1315
Invesco Biotechnology & Genome ETF
PBE
$282M
$66K ﹤0.01%
1,579
PFI icon
1316
Invesco Dorsey Wright Financial Momentum ETF
PFI
$59.5M
$66K ﹤0.01%
2,141
SWX icon
1317
Southwest Gas
SWX
$6.66B
$66K ﹤0.01%
800
ACC
1318
DELISTED
American Campus Communities, Inc.
ACC
$66K ﹤0.01%
1,400
VAL
1319
DELISTED
Valspar
VAL
$66K ﹤0.01%
601
+18
+3% +$1.98K
PNC.PRP
1320
DELISTED
THE PNC FINANCIAL SERVICES GROUP, INC.
PNC.PRP
$66K ﹤0.01%
2,350
PWJ
1321
DELISTED
POWERSHARES DYNAMIC MID CAP GRTH PORTFOLIO
PWJ
$66K ﹤0.01%
1,956
VPU
1322
Vanguard Utilities ETF
VPU
$8.72B
$65K ﹤0.01%
582
-400
-41% -$43.9K
MTUS icon
1323
Metallus
MTUS
$869M
$65K ﹤0.01%
3,440
LSXMA
1324
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$65K ﹤0.01%
2,377
-73
-3% -$1.97K
TWTR
1325
DELISTED
Twitter, Inc.
TWTR
$65K ﹤0.01%
4,470
+3,340
+296% +$54.2K

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.